Journey Medical Corp Shareholders Back Key Proposals
Company Announcements

Journey Medical Corp Shareholders Back Key Proposals

An update from Journey Medical Corp (DERM) is now available.

During the 2024 Annual Meeting, Journey Medical Corporation successfully passed three key proposals via a virtual platform with a strong stockholder turnout. Shareholders voted to elect five directors until the next annual meeting, ratified KPMG LLP as the independent accounting firm for the upcoming year, and approved an amendment to the company’s 2015 Stock Incentive Plan. The decisions, reflecting nearly 62% of eligible voting shares, underscore stockholder confidence and pave the way for the company’s strategic direction in the following year.

Find detailed analytics on DERM stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyJourney Medical price target raised to $11 from $8.50 at Alliance Global Partners
TheFlyJourney Medical announces U.S. FDA approval of Emrosi
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App